These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 2547216)

  • 1. [Adjuvant therapy of non-small cell bronchial cancer with mopidamol].
    Blaha H; Dierkesmann R; Feuerer W; Gatzemaier U; Geser C; Lemme J; Mall W; Ritscher R; Schneider B; Vallee D
    Pneumologie; 1989 Jun; 43(6):299-304. PubMed ID: 2547216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misonidazole combined with radiotherapy in the treatment of non-small cell lung cancer. A randomized double-blind trial.
    Jakobsson M; Taskinen PJ; Kylmämaa T
    Strahlenther Onkol; 1987 Feb; 163(2):90-3. PubMed ID: 3031840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin.
    Rowinsky EK; Jiroutek M; Bonomi P; Johnson D; Baker SD
    Clin Cancer Res; 1999 Apr; 5(4):767-74. PubMed ID: 10213211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors in operated non-small cell cancer of the lung. Study from a randomized therapeutic trial].
    Bénichou J; Fabre C; Chastang C; Lebeau B; Babo P; Rebishung JL; Lepage T; Fichet D; Decroix G
    Rev Mal Respir; 1987; 4(6):301-9. PubMed ID: 2831594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
    James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
    Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA;
    J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
    Xu G; Rong T; Lin P
    Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.
    Choy H; LaPorte K; Knill-Selby E; Mohr P; Shyr Y
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):90-6. PubMed ID: 10210546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
    Johnson EA; Marks RS; Mandrekar SJ; Hillman SL; Hauge MD; Bauman MD; Wos EJ; Moore DF; Kugler JW; Windschitl HE; Graham DL; Bernath AM; Fitch TR; Soori GS; Jett JR; Adjei AA; Perez EA
    Lung Cancer; 2008 May; 60(2):200-7. PubMed ID: 18045731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.
    Zacharski LR; Moritz TE; Baczek LA; Rickles FR; Edwards RL; Forman WB; Forcier RJ; Cornell CJ; Haakenson CM; Ballard HS
    J Natl Cancer Inst; 1988 Mar; 80(2):90-7. PubMed ID: 2830407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mopidamol in non-small cell lung cancer: anti-oncogene or accident?
    Livingston RB
    J Natl Cancer Inst; 1988 Mar; 80(2):77-8. PubMed ID: 2830406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.